Harding Loevner’s QIAGEN NV QGENF Stock Holding History

Harding Loevner’s Portfolio QGENF Stock Details QGENF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-1,687,192	Closed	-$38.4M	–	94
2014 Q3	$38.4M	Sell	1,687,192 -5,291,177	-76%	-$120M	0.28%	65
2014 Q2	$171M	Buy	6,978,369 +15,687	+0.2%	+$384K	1.27%	36
2014 Q1	$147M	Sell	6,962,682 -35,169	-0.5%	-$742K	1.12%	40
2013 Q4	$167M	Buy	6,997,851 +49,522	+0.7%	+$1.18M	1.29%	34
2013 Q3	$149M	Buy	6,948,329 +559,577	+9%	+$12M	1.33%	31
2013 Q2	$127M	Buy	+6,388,752	New	+$127M	1.23%	33

Other funds holding QGENF

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

HJGA

Hardman Johnston Global Advisors Stamford, Connecticut $2.1B AUM 41.89% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Credit Agricole Montrouge Cedex, France $38.1B AUM

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

CRM

Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return

Harding Loevner's QGENF Position: Q4 2014 in Review

Harding Loevner sold out of QIAGEN NV (QGENF) in Q4 2014, closing a stake of 1,687,192 shares — an estimated $38.4M sold.

Harding Loevner first reported a position in QGENF in Q2 2013 and held it in 6 quarters. The position peaked at $171M in Q2 2014. 172 funds tracked by Wall St. Rank hold QGENF as of Q4 2014.

Harding Loevner reported no remaining QIAGEN NV position as of Q4 2014 after selling out during the quarter.
Harding Loevner sold 1,687,192 QIAGEN NV shares in Q4 2014, an estimated $38.4M.
Harding Loevner first reported a position in QIAGEN NV in Q2 2013 and held it in 6 quarters.
Harding Loevner's QIAGEN NV position peaked at $171M in Q2 2014.
172 funds tracked by Wall St. Rank held QIAGEN NV as of Q4 2014.

Based on Harding Loevner's 13F filing for Q4 2014, filed 12 Jan 2015.